Show simple item record

dc.contributor.advisorSyarif, Firman
dc.contributor.authorTiomar, Peter
dc.date.accessioned2022-11-28T07:14:42Z
dc.date.available2022-11-28T07:14:42Z
dc.date.issued2022
dc.identifier.urihttps://repositori.usu.ac.id/handle/123456789/66413
dc.description.abstractThis study aims to determine the effect of the concentration of Profit Margin on Sales Ratio, Net Profit Margin Ratio, Current Ratio, Earning Per Share Ratio, Debt to Equity Ratio, and Net Sales Growth Ratio on Hedging Decisions in pharmaceutical companies listed on the Indonesia Stock Exchange for the 2017-2020 period. The data used is secondary data derived from the company's annual report which can be accessed through the Indonesia Stock Exchange website (www.idx.co.id). The population of this study consisted of 10 companies. The data collection method used was purposive sampling method and obtained 8 sample companies for 4 observation periods (2017-2020) with a total of 32 total research observations. Data processing using SPSS 24 software and the analysis used is logistic regression analysis. The results contained in this study is the Net Profit Margin Ratio partially negative and has a significant effect on hedging decisions. Current Ratio partially has a positive effect and significant effect on hedging decisions. Profit Margin on Sales Ratio negative, but has not significant effect on hedging decisions. Earning Per Share Ratio partially negative, but has not significant effect on hedging decisions. Debt to Equity Ratio partially positive, but has not significant effect on hedging decisions. Net Sales Growth Ratio partially negative, but has not significant effect on hedging decisions.en_US
dc.language.isoiden_US
dc.publisherUniversitas Sumatera Utaraen_US
dc.subjectProfit Margin on Sales Ratioen_US
dc.subjectNet Profit Margin Ratioen_US
dc.subjectCurrent Ratioen_US
dc.subjectEarning Per Share Ratioen_US
dc.subjectDebt to Equity Ratioen_US
dc.subjectNet Sales Growth Ratioen_US
dc.subjectHedging Decisionen_US
dc.titlePengaruh Profit Margin On Sales Ratio, Net Profit Margin Ratio, Current Ratio, Earning Per Share Ratio, Debt To Equity Ratio, dan Net Sales Growth Ratioterhadap Keputusan Hedgingpada Perusahaan Farmasi yang terdaftar di Bursa Efek Indonesia Tahun 2017-2020en_US
dc.typeThesisen_US
dc.identifier.nimNIM180503121
dc.identifier.nidnNIDN0004096703
dc.identifier.kodeprodiKODEPRODI62201#Akuntansi
dc.description.pages141 Halamanen_US
dc.description.typeSkripsi Sarjanaen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record